Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG® in Volunteers With Existing Botulinum Immunity
Latest Information Update: 11 Nov 2024
At a glance
- Drugs Botulism vaccine (Primary)
- Indications Botulism
- Focus Therapeutic Use
Most Recent Events
- 06 Nov 2024 Status changed from recruiting to active, no longer recruiting.
- 16 Jul 2024 Status changed from not yet recruiting to recruiting.
- 07 Nov 2023 New trial record